Experimental DNA-Launched Live-Attenuated Vaccines Against Yellow Fever
Background DNA-launched vaccine is “manufactured” in vaccinated individuals and does not require traditional vaccine manufacturing facility and technology. Goals. Using yellow fever 17D vaccine, we have provided proof-of-concept evidence that these vaccine can be launched from DNA and induce specifi...
Saved in:
| Main Authors: | P. Pushko, А. А. Ishmukhametov, P. P. Bredenbeek, I. S. Lukashevich |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2019-03-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/657 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Immunogenicity of the Attenuated Yellow Fever Vaccine in Several Neotropical Primate Species
by: Nayara Ferreira de Paula, et al.
Published: (2025-04-01) -
Plasmid DNA Delivery into the Skin via Electroporation with a Depot-Type Electrode
by: Yuya Yoshida, et al.
Published: (2024-09-01) -
Vaccination against yellow fever in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-10-01) -
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies
by: Chasity D. Andrews, et al.
Published: (2020-01-01) -
Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil
by: Max McClure, et al.
Published: (2025-01-01)